Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Famous Network programs in Europe and America - 2Iran steps up executions as experts warn state killing being used to suppress political dissent
- 3Recent studies prove the ancient practice of nasal irrigation is effective at fighting the common cold
- 4Artemis will take Americans to the moon for the 1st time since 1972. Why has it been so hard to go back?
- 5Netflix's 'Lord of the Flies' show blends 'Adolescence' and 'Yellowjackets'
- African Forests Have Become a Source of Carbon Emissions
- The Most Vital Crossroads in Olympic History
- Banks for High Fixed Store Rates: Amplify Your Reserve funds
- What’s the shadowy organisation taking Gaza Palestinians to South Africa?
- At least 55 injured in Russia after train crashes, overturns
- CPA Canada appoints eight directors as new governance model takes effect
- JW Marriott Tokyo: an elegant retreat amid whirlwind of the city
- Florida has quietly become America's execution capital
- South America's Memorable Destinations: A Movement Guide
